Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/24/2017 04/25/2017 04/26/2017 04/27/2017 04/28/2017 Date
2.4(c) 2.55(c) 2.57(c) 2.63(c) 2.56(c) Last
1 423 869 2 630 841 2 446 583 2 185 701 1 580 973 Volume
+0.84% +6.25% +0.78% +2.33% -2.66% Change
More quotes
Financials ($)
Sales 2017 15,7 M
EBIT 2017 -22,2 M
Net income 2017 -35,8 M
Debt 2017 -
Yield 2017 -
Sales 2018 41,0 M
EBIT 2018 0,27 M
Net income 2018 1,00 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 512,00
Capi. / Sales2017 26,0x
Capi. / Sales2018 9,94x
Capitalization 407 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
04/29 Metropolitan Life Insurance Co. NY Has $233,000 Stake in Geron Co.
04/25 Geron 2017 Annual Meeting of Stockholders to be Held on May 9
04/11 GERON : Announces Completion of Second Internal Data Reviews for Imetelstat Tria..
04/10 GERON CORP : Other Events (form 8-K)
04/10 GERON CORPORATION : (GERN) Jumps on Data Reviews
04/10 Geron Announces Completion of Second Internal Data Reviews for Imetelstat Tri..
04/09 GERON ANNOUNCES CONFERENCE CALL ON A : 00 A.M. Eastern Time
04/06 GERON : New Study Could Signal Geron`s Return To Oncology
04/05 Geron Reports Imetelstat Presentation at American Association for Cancer Rese..
03/20 GERON CORPORATION : Today's Research Reports on Stocks to Watch: Geron and Galen..
More news
Sector news : Bio Therapeutic Drugs
04/28 REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
04/28DJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
04/27 AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
More sector news : Bio Therapeutic Drugs
Latest Tweets
04/28Geron $GERN Receiving Somewhat Favorable Press Coverage, Analysis Shows  
04/263 Things In Biotech You Should Learn Today: April 26, 2017  
04/26Geron 2017 Annual Meeting Of Stockholders To Be Held On May 9  
04/25Geron 2017 Annual Meeting of Stockholders to be Held on May 9  
04/18Snippet Roundup: Aerie Stumbles On Safety; Stada Is Sold At Last $AERI $STDAF.. 
More tweets
Qtime:18
News from SeekingAlpha
04/26 3 THINGS IN BIOTECH YOU SHOULD LEARN : April 26, 2017
04/18 SNIPPET ROUNDUP : Aerie Stumbles On Safety; Stada Is Sold At Last
04/17 Staking A Claim To Geron
04/11 AFTER HOURS GAINERS / LOSERS AS OF 5 : 25 pm
04/10 Geron settling class-action securities suit for $6.25M
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 4,17 $
Spread / Average Target 63%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Ho Young Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Independent Director
Robert Jay Spiegel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION23.67%407
AMGEN, INC.11.70%120 105
CELGENE CORPORATION7.17%96 861
GILEAD SCIENCES, INC.-4.27%89 611
REGENERON PHARMACEUTIC..5.83%41 293
VERTEX PHARMACEUTICALS..60.58%29 390
More Results